Mycronic AB (publ) carries a market capitalization of 60.18B, placing it among publicly traded companies globally. Its enterprise value stands at 37.77B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 60.18B |
| Enterprise Value | 37.77B |
Mycronic AB (publ) currently has 195.18M shares outstanding.
| Shares Outstanding | 195.18M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Mycronic AB (publ) trades at a trailing price-to-earnings ratio of 19.95.
| PE Ratio | 19.95 |
| PS Ratio | 4.89 |
| PB Ratio | N/A |
| P/TBV Ratio | 12.72 |
| P/FCF Ratio | 27.74 |
| P/OCF Ratio | 27.71 |
On an enterprise value basis, Mycronic AB (publ) trades at an EV/EBITDA multiple of 15.36 and an EV/FCF ratio of 26.58. The EV/Sales ratio of 4.69 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.36 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.69 |
| EV / EBITDA | 15.36 |
| EV / EBIT | 15.36 |
| EV / FCF | 26.58 |
Mycronic AB (publ) maintains a current ratio of 2.16, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.16 |
| Quick Ratio | 0.66 |
| Debt / Equity | 2.91 |
| Debt / EBITDA | 0.08 |
| Interest Coverage | N/A |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 20.31 |
| Return on Invested Capital (ROIC) | 30.82 |
| Return on Capital Employed (ROCE) | 960.49 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.80 |
Over the trailing twelve months, Mycronic AB (publ) has paid 483.00M in income taxes, reflecting an effective tax rate of 19.61.
| Income Tax | 483.00M |
| Effective Tax Rate | 19.61 |
Mycronic AB (publ)'s stock has gained approximately 60.38718% over the past 52 weeks. The 50-day moving average sits at 270.26, while the 200-day moving average is 225.95.
| Beta (5Y) | N/A |
| 52-Week Price Change | 60.38718% |
| 50-Day Moving Average | 270.26 |
| 200-Day Moving Average | 225.95 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Mycronic AB (publ) generated 8.05B in revenue and converted that into 1.97B in net income, yielding earnings per share of 10.14. EBITDA reached 2.46B, while operating income came in at 2.46B.
| Revenue | 8.05B |
| Gross Profit | 4.38B |
| Operating Income | 2.46B |
| Pretax Income | 2.46B |
| Net Income | 1.97B |
| EBITDA | 2.46B |
| EBIT | 2.46B |
| Earnings Per Share (EPS) | 10.14 |
Mycronic AB (publ) holds 1.80B in cash and equivalents against 197.00M in total debt, resulting in a net debt position of -1.80B.
| Cash & Cash Equivalents | 1.80B |
| Total Debt | 197.00M |
| Net Debt | -1.80B |
| Equity (Book Value) | N/A |
| Book Value Per Share | N/A |
| Working Capital | 3.16B |
Mycronic AB (publ) produced 1.42B in operating cash flow over the past twelve months.
| Operating Cash Flow | 1.42B |
| Capital Expenditures | N/A |
| Free Cash Flow | 1.42B |
| FCF Per Share | 7.28 |
Mycronic AB (publ) operates with a gross margin of 54.37, reflecting its pricing power and cost economics. The operating margin of 30.56 and net profit margin of 24.53 provide insight into operational efficiency.
| Gross Margin | 54.37 |
| Operating Margin | 30.56 |
| Pretax Margin | 30.61 |
| Profit Margin | 24.53 |
| EBITDA Margin | 30.56 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 2.15 |
| FCF Yield | 3.60 |
Mycronic AB (publ)'s most recent stock split took place on June 3, 2025 with a 1:2 split ratio.
| Last Split Date | 6/3/2025 |
| Split Ratio | 1:2 |
Mycronic AB (publ) posts an Altman Z-Score of 9.61, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 9.61 |